Vecuronium
- Generic Name
- Vecuronium
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C34H57N2O4
- CAS Number
- 86029-43-8
- Unique Ingredient Identifier
- 5438723848
- Background
Monoquaternary homolog of pancuronium. A non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium. Its lack of significant cardiovascular effects and lack of dependence on good kidney function for elimination as well as its short duration of action and easy reversibility provide advantages over, or alternatives to, other...
- Indication
Vecuronium is a muscle relaxing agent and is used as an adjunct in general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- General Anesthesia, Facilitation of small bowel intubation therapy, Smooth muscle relaxation prior to radiological procedures therapy
Opioid-Free Shoulder Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- OrthoCarolina Research Institute, Inc.
- Target Recruit Count
- 86
- Registration Number
- NCT03540030
- Locations
- 🇺🇸
OrthoCarolina Research Institute, Charlotte, North Carolina, United States
Evaluation of Atracurium-vecuronium Combination in Laparosocpic Surgery
- Conditions
- Interventions
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2017-12-14
- Lead Sponsor
- Sir Ganga Ram Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT03371953
- Locations
- 🇮🇳
Sir Ganga Ram Hospital, New Delhi, Delhi, India
Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 344
- Registration Number
- NCT03346057
- Locations
- 🇺🇸
Mission Hospital - Memorial ( Site 1016), Asheville, North Carolina, United States
🇺🇸Cleveland Clin Foundation ( Site 1032), Cleveland, Ohio, United States
🇺🇸Hermann Drive Surgical Center ( Site 1021), Houston, Texas, United States
Intraoperative Lidocaine Infusion vs. Esmolol Infusion for Postoperative Analgesia in Laparoscopic Cholecystectomy
- First Posted Date
- 2014-12-31
- Last Posted Date
- 2018-11-30
- Lead Sponsor
- B.P. Koirala Institute of Health Sciences
- Target Recruit Count
- 90
- Registration Number
- NCT02327923
- Locations
- 🇳🇵
BP Koirala Institute of Health Sciences, Dharan, Sunsari District, Nepal
A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part B: Caucasian Participants (P05971)
- Conditions
- Interventions
- First Posted Date
- 2007-11-02
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 100
- Registration Number
- NCT00552617
Comparison of Sugammadex (MK-8616/Org 25969) With Neostigmine Administered at 1-2 Post-tetanic Counts (PTCs) After Administration of Rocuronium or Vecuronium (19.4.302/P05945/MK-8616-025)
- Conditions
- Interventions
- First Posted Date
- 2007-05-15
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 182
- Registration Number
- NCT00473694
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.